/Insulet%20Corporation%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Acton, Massachusetts-based Insulet Corporation (PODD) develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. With a market cap of $16.6 billion, Insulet’s operations span the United States, Canada, Europe, the Middle East, Australia, and internationally.
Companies worth $10 billion or more are generally described as "large-cap stocks," Insulet fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size, influence, and dominance in the medical devices industry. It was the first medical device manufacturer to develop a tubeless insulin delivery system and a mobile app that helps people manage their diabetes remotely.